COCP · Cocrystal Pharma, Inc.
$1.09
-0.03 (-2.68%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2026, the Company recorded a net loss of approximately $5,463 and used approximately $4,856 of cash in operating activities. These factors raise substantial doubt about the Company's ability to continue as a going concern. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$21.38M
Shares
19.26M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
376,588
-2.9% vs reported
Short Squeeze Score
65/100
Short interest 2.0% of shares — P51
Days to cover 14.2 — P94
Price vs VWAP +4.4% — P66
Short-volume trend +4.9% — P70
Short interest change -1.8% — P48
Worst FTD 0.01% of shares — P54
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 388,004 | 395,023 | -7,019 | 14.15 |
| 2026-07-15 | 395,023 | 404,505 | -9,482 | 14.86 |
| 2026-06-30 | 404,505 | 410,154 | -5,649 | 4.47 |
| 2026-06-15 | 410,154 | 143,168 | +266,986 | 3.77 |
| 2026-05-29 | 143,168 | 192,682 | -49,514 | 1.09 |
| 2026-05-15 | 192,682 | 586,422 | -393,740 | 1.40 |
| 2026-04-30 | 586,422 | 988,346 | -401,924 | 3.10 |
| 2026-04-15 | 988,346 | 148,911 | +839,435 | 1.00 |
| 2026-03-31 | 148,911 | 214,196 | -65,285 | 2.96 |
| 2026-03-13 | 214,196 | 263,840 | -49,644 | 6.17 |
| 2026-02-27 | 263,840 | 236,076 | +27,764 | 5.78 |
| 2026-02-13 | 236,076 | 202,066 | +34,010 | 3.17 |
| 2026-01-30 | 202,066 | 160,347 | +41,719 | 3.02 |
| 2026-01-15 | 160,347 | 131,425 | +28,922 | 1.58 |
| 2025-12-31 | 131,425 | 127,449 | +3,976 | 1.49 |
| 2025-12-15 | 127,449 | 138,793 | -11,344 | 2.53 |
| 2025-11-28 | 138,793 | 176,402 | -37,609 | 1.87 |
| 2025-11-14 | 176,402 | 261,762 | -85,360 | 2.13 |
| 2025-10-31 | 261,762 | 247,407 | +14,355 | 1.08 |
| 2025-10-15 | 247,407 | 261,648 | -14,241 | 1.39 |
| 2025-09-30 | 261,648 | 981,239 | -719,591 | 1.00 |
| 2025-09-15 | 981,239 | 41,190 | +940,049 | 1.00 |
| 2025-08-29 | 41,190 | 27,491 | +13,699 | 1.50 |
Showing 1–23 of 23 settlements
Key facts
CIK
1412486
CUSIP
19188J409
13F (30d)
29 filings
29 filers
Visit website
Investor relations